Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
About | EpimAb
EpimAb Biotherapeutics Submits Hong Kong IPO Application as Biotech ...
EpimAb Biotherapeutics Announces FDA Clearance of its IND Application ...
EpimAb Biotherapeutics Announces the First CTA Filing of a FIT-IG ...
EpimAb Biotherapeutics and Innovent Biologics Announce Multi-Target ...
EpimAb Biotherapeutics Updates IPO Filing: China’s TCE Pioneer Turns ...
EpimAb Biotherapeutics Appoints Industry Veteran Bin Peng as Chief ...
Company Culture | EpimAb
FIT-Ig® | EpimAb
EpimAb Biotherapeutics, Inc. on LinkedIn: #bispecific #biotech # ...
EpimAb Biotherapeutics, Inc. | LinkedIn
EpimAb Biotherapeutics will present the first-in-human results for EMB ...
Candid Therapeutics Teams Up with EpimAb Biotherapeutics, Inc ...
China Healthcare Summit 2026 | EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics - 2026 Company Profile, Team, Funding ...
#immunooncology | EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics completes Series B financing - Chinadaily.com.cn
Congratulations to the team at EpimAb Biotherapeutics, Inc. on their ...
EpimAb Biotherapeutics to Showcase Innovations at SITC 2024 - Investors ...
PipeLine | EpimAb
EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal ...
LSX World Congress 2019 Presentations - EpimAb Biotherapeutics - YouTube
Home | EpimAb
Shanghai’s EpimAb Completes $74 Million Series B for Bi-Specific ...
EpimAb People | EpimAb
China's EpimAb raises $25m in Series A round led by Oriza Seed
Medigene and EpimAb Partner to Advance Off-the-Shelf TCR-TCE Therapies ...
Medigene and EpimAb Biotherapeutics: A Powerful Alliance for TCR-Guided ...
EpimAb Biotherapeutics, Inc. on LinkedIn: #PEGS22 #bispecific #innovation
CEO EPIMAB BIOTHERAPEUTICS – Dr. Chengbin Wu – The Business Insight
EpimAb Biotherapeutics, Inc. on LinkedIn: #cfo #chinabiotech #bispecifics
利用 EpimAb 生物技术开创癌症治疗新纪元 - 0x资讯
Partnering Strategy | EpimAb
Shanghai-based EpimAb Bio grows global roots with $25M A round and a ...
News | EpimAb
The first bispecific antibody (anti-PD-L1/OX40 Ab, aka EMB-09 by EpimAb ...
Events | EpimAb
epimab THOR Serum Protein GEL Components - YouTube
Epimab Biotherapeutics raises $120M series C to advance clinical ...
Existing Partnerships | EpimAb
Medigene and EpimAb Biotherapeutics Enter into a Co-Development ...
EpimAb Biotherapeutics, Inc. (上海岸迈生物科技有限公司) - 药物管线_专利_临床试验_投融营收_最新药物:甲 ...
EpimAb Biotherapeutics, Inc. on LinkedIn: #chinabio #chinabiopartnering
Acuerdo entre Almirall y EpimAb Biotherapeutics
AlmirallAlmirall partners with EpimAb to develop bispecific antibodies
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research ...
EpimAb Biotherapeutics and Vignette Bio collaborate | Biotechnology ...
Asher raises $55M; Roche's Huntington's trial; EpimAb bags $120M
6 Takeaways from EpimAb's $210 Million NewCo - Case Study - Unibest ...
Very pleased to have this exciting multi target collaboration signed ...
EpimAb|岸迈生物【官网】
FDA clears EpimAb’s IND for trial of cancer combo therapy
TCG Labs' Juri Biosciences Secures $210M Deal for EpimAb’s Prostate ...
Fabs-in-tandem Immunoglobulin And Uses Thereof WU; Chengbin [EpimAb ...
Endpoints News covers our $120M Series C financing, plans for ...
June 8 2023
Chinese biotech firm boosts funding, plans IPO next to catch European ...
国内潜力双抗平台巡礼：EpimAb|投资|生物|临床|EMB-|药物|-健康界
Fabs-in-tandem immunoglobulin and uses thereof Patent Grant Wu Dec ...
Look forward to moderating a panel at the upcoming BFC conference Jan 7 ...
